Neurogene Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NGNE Key Statistics
Stock Snapshot
The current Neurogene Inc(NGNE) stock price is $22.13, with a market capitalization of 341.7M. The stock trades at a price-to-earnings (P/E) ratio of -5.00.
During the trading session on 2026-03-06, Neurogene Inc(NGNE) shares reached a daily high of $25.43 and a low of $22.00. At a current price of $22.13, the stock is +0.6% higher than the low and still -13.0% under the high.
Trading activity shows a volume of 254.64K, compared to an average daily volume of 326.37K.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.